BeStock  
股票 › 传染病 › TMO

赛默飞世尔科技 TMO

美股市值排名 #59传染病机器人
$694.76 +$17.82 (+2.63%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $694.76 0.00%
开盘$669.20
昨收$676.94
当日区间$661.60 – $697.78
成交量2.09M
市值$257.42B
市盈率(TTM)36.6
股息率0.26%

基本面

最新报告季度:Q3, ended Sep 2026

营收$12.14B+9.1% YoY
营业利润$2.46B+18.7% YoY
净利润$1.73B+6.5% YoY
摊薄每股收益$4.64+8.7% YoY
自由现金流$2.11B+15.1% YoY
经营现金流$2.55B

营收,近8个季度

$11.4BDec '24$10.4BMar '25$10.9BJun '25$11.1BSep '25$12.2BDec '25$11.0BMar '26$12.0BJun '26$12.1BSep '26

净利润,近8个季度

$1.8BDec '24$1.5BMar '25$1.6BJun '25$1.6BSep '25$2.0BDec '25$1.7BMar '26$1.7BJun '26$1.7BSep '26

各季度摊薄每股收益

4.78Dec '243.98Mar '254.28Jun '254.27Sep '255.21Dec '254.43Mar '264.68Jun '264.64Sep '26

各季度自由现金流

$2.8BDec '24$361.0MMar '25$1.1BJun '25$1.8BSep '25$3.0BDec '25$816.0MMar '26$1.7BJun '26$2.1BSep '26

年度营收

$32.2BFY20$39.2BFY21$44.9BFY22$42.9BFY23$42.9BFY24$44.6BFY25

盈利能力与资产负债表

毛利率41.4%
营业利润率18.7%
净利率14.9%
净资产收益率13.4%
资产收益率6.5%
投入资本回报率8.3%
流动比率1.81
负债/资产比率51.9%
现金及投资$6.06B
总负债$41.37B
净现金(净负债)-$35.31B
自由现金流/营收16.0%

营收构成

2026/Q2 季度

按业务线

  • Laboratory Products and Biopharma Services$6.69B 53.3%
  • Life Sciences Solutions$2.82B 22.4%
  • Analytical Instruments$1.85B 14.7%
  • Specialty Diagnostics$1.21B 9.6%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $12.14B $11.99B $11.01B $44.56B $12.22B
营业总收入 $12.14B $11.99B $11.01B $44.56B $12.22B
营业成本 $6.95B $7.11B $6.58B $26.32B $7.20B
毛利润 $5.19B $4.88B $4.43B $18.24B $5.01B
营业费用 $2.73B $2.70B $2.52B $10.13B $2.71B
销售及管理费用 $1.86B $2.33B $2.18B $8.73B $2.35B
研发费用 $348.00M $364.00M $336.00M $1.40B $356.00M
折旧、摊销与折耗 $519.00M – – – –
-折旧与摊销 $519.00M – – – –
营业利润 $2.46B $2.19B $1.91B $8.11B $2.30B
非经营性利息净收入(支出) -$165.00M -$194.00M -$121.00M -$426.00M -$107.00M
非经营性利息收入 $252.00M $207.00M $233.00M $993.00M $258.00M
非经营性利息支出 $417.00M $401.00M $354.00M $1.42B $365.00M
其他收入(支出) -$209.00M -$67.00M -$58.00M -$374.00M -$40.00M
特殊收益(费用) -$199.00M -$98.00M -$49.00M -$362.00M -$46.00M
-减:重组及并购费用 $199.00M $98.00M $49.00M $362.00M $46.00M
其他非经营性收入(支出) -$10.00M $31.00M -$9.00M -$25.00M -$7.00M
税前利润 $2.09B $1.92B $1.73B $7.31B $2.15B
税费 $352.00M $167.00M $70.00M $547.00M $153.00M
权益法投资税后收益 -$9.00M -$15.00M -$8.00M -$41.00M -$32.00M
净利润 $1.73B $1.74B $1.66B $6.72B $1.97B
持续经营利润 $1.73B $1.74B $1.66B $6.72B $1.97B
少数股东权益 $6.00M $5.00M $5.00M $17.00M $6.00M
归属母公司净利润 $1.72B $1.74B $1.65B $6.70B $1.96B
归属普通股股东净利润 $1.72B $1.74B $1.65B $6.70B $1.96B
基本每股收益 $4.65 $4.68 $4.44 $17.77 $5.22
摊薄每股收益 $4.64 $4.68 $4.43 $17.74 $5.21
每股股息 $0.47 $0.47 $0.47 $1.72 $0.43
证券出售收益 – – – $13.00M –

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $114.23B $113.17B $113.28B $110.34B $110.34B
流动资产合计 $25.62B $23.37B $22.32B $28.71B $28.71B
现金及现金等价物与短期投资 $6.06B $4.06B $3.26B $10.11B $10.11B
-现金及现金等价物 $5.46B $4.06B $3.25B $9.85B $9.85B
-短期投资 $600.00M $0.00 $2.00M $253.00M $253.00M
应收款 $9.63B $11.14B $10.89B $10.57B $10.57B
-应收账款 $9.63B $9.45B $9.20B $8.90B $8.90B
存货 $5.64B $5.63B $5.50B $5.43B $5.43B
其他流动资产 $4.29B $2.54B $2.68B $2.61B $2.61B
非流动资产合计 $88.62B $89.81B $90.96B $81.64B $81.64B
固定资产净值 $10.58B $10.76B $10.66B $10.57B $10.57B
商誉及其他无形资产 $72.34B $73.44B $74.33B $65.20B $65.20B
-商誉 $54.26B $54.83B $55.19B $49.36B $49.36B
-其他无形资产 $18.08B $18.61B $19.15B $15.84B $15.84B
其他非流动资产 $5.70B $5.62B $5.97B $5.87B $5.87B
负债合计 $59.34B $60.37B $61.22B $56.81B $56.81B
流动负债合计 $14.17B $15.07B $14.62B $15.19B $15.19B
短期债务及融资租赁负债 $2.26B $3.37B $3.09B $3.53B $3.53B
-一年内到期债务 $2.26B $3.37B $3.09B $3.53B $3.53B
其他流动负债 $11.91B -$2.00M – – –
非流动负债合计 $45.17B $45.30B $46.60B $41.62B $41.62B
长期债务及融资租赁负债 $39.11B $39.18B $40.07B $35.85B $35.85B
-长期债务 $39.11B $39.18B $40.07B $35.85B $35.85B
其他非流动负债 $6.06B $4.54B $4.42B $4.27B $4.27B
股东权益合计 $54.90B $52.81B $52.06B $53.54B $53.54B
股东权益 $54.77B $52.68B $51.93B $53.41B $53.41B
少数股东权益 $128.00M $128.00M $128.00M $129.00M $129.00M
-其他应收款 – $1.69B $1.68B $1.67B $1.67B
应付款 – $3.27B $3.34B $3.62B $3.62B
-应付账款 – $3.27B $3.34B $3.62B $3.62B
一年内应计费用 – $5.52B $5.26B $5.32B $5.32B
一年内递延负债 – $2.92B $2.93B $2.71B $2.71B
一年以上递延负债 – $1.58B $2.11B $1.49B $1.49B
股本 – $446.00M $445.00M $445.00M $445.00M
-普通股 – $446.00M $445.00M $445.00M $445.00M
-优先股 – $0.00 $0.00 $0.00 $0.00
资本公积 – $18.87B $18.71B $18.56B $18.56B
留存收益 – $62.19B $60.63B $59.16B $59.16B
减:库存股 – $26.37B $25.36B $22.31B $22.31B
不影响留存收益的损益 – -$2.46B -$2.50B -$2.45B -$2.45B
-固定资产原值 – – – $18.38B $18.38B
-累计折旧 – – – -$7.82B -$7.82B

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $2.55B $2.13B $1.19B $7.82B $3.46B
持续经营经营活动现金流净额 $2.55B $2.12B $1.19B $7.82B $3.46B
持续经营净利润 $1.73B $1.74B $1.66B $6.72B $1.97B
折旧、折耗与摊销 $825.00M $817.00M $736.00M $2.78B $728.00M
递延税款 -$210.00M -$208.00M -$258.00M -$639.00M $89.00M
其他非现金项目 $416.00M $118.00M $87.00M $412.00M $97.00M
营运资金变动 -$43.00M -$425.00M -$1.11B -$1.77B $489.00M
投资活动现金流净额 -$77.00M $164.00M -$8.96B -$4.05B $891.00M
持续经营投资活动现金流净额 -$77.00M $165.00M -$8.96B -$4.05B $892.00M
固定资产购置及出售净额 -$436.00M -$446.00M -$367.00M -$1.48B -$438.00M
业务购买及出售净额 $1.02B $0.00 -$8.87B -$4.04B $0.00
投资购置及出售净额 -$629.00M $554.00M $332.00M $1.45B $1.33B
其他投资变动净额 -$28.00M $56.00M -$54.00M $21.00M $0.00
筹资活动现金流 -$1.06B -$1.57B $1.09B $1.80B $3.53B
持续经营筹资活动现金流净额 -$1.06B -$1.57B $1.09B $1.80B $3.53B
债务发行及偿还净额 -$1.11B -$389.00M $4.22B $5.35B $3.63B
普通股发行净额 $0.00 -$1.00B -$3.00B -$3.00B -$37.00M
已付现金股利 -$174.00M -$175.00M -$162.00M -$636.00M -$162.00M
其他筹资费用净额 $218.00M -$7.00M $40.00M $90.00M $91.00M
期末现金余额 $5.49B $4.10B $3.28B $9.88B $9.88B
现金净变动 $1.41B $718.00M -$6.68B $5.57B $7.87B
期初现金余额 $4.10B $3.28B $9.88B $4.04B $2.01B
汇率变动影响 -$12.00M $98.00M $78.00M $267.00M -$6.00M
自由现金流 $2.11B $1.68B $816.00M $6.29B $2.99B
-应收款变动 – – – -$426.00M –
-存货变动 – – – -$74.00M –
-应付账款及应计费用变动 – – – $421.00M –
-其他营运资金变动 – – – -$1.69B –

讨论区

暂无评论——快来第一个聊聊 TMO。

发表评论

Scroll to Top